Lutz Wollin
Biberach An Der Riss, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Targeting the epithelium in pulmonary fibrosis.
Journal: European respiratory review : an official journal of the European Respiratory Society
Published: September 23, 2025
Proof of Pharmacology, Safety, and Pharmacokinetics of the Novel TRPA1 Antagonist BI 1839100: A Randomized, Placebo-Controlled, Parallel Group, First-In-Human Study in Healthy Male Participants.
Journal: Clinical and translational science
Published: January 21, 2025
Objective measurement of cough in pulmonary fibrosis: a cohort study - ImpaCT.
Journal: ERJ open research
Published: March 28, 2024
PDE4B inhibition by nerandomilast: Effects on lung fibrosis and transcriptome in fibrotic rats and on biomarkers in human lung epithelial cells.
Journal: British journal of pharmacology
Published: February 22, 2024
Anti-fibrotic effects of nintedanib on lung fibroblasts derived from patients with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs).
Journal: Pulmonary pharmacology & therapeutics
Published: July 05, 2023
Corrigendum: BI 1015550 is a PDE4B inhibitor and a clinical drug candidate for the oral treatment of idiopathic pulmonary fibrosis.
Journal: Frontiers in pharmacology
Published: May 09, 2023
BI 1015550 is a PDE4B Inhibitor and a Clinical Drug Candidate for the Oral Treatment of Idiopathic Pulmonary Fibrosis.
Journal: Frontiers in pharmacology
Published: December 17, 2021
Arsenic trioxide inhibits the functions of lung fibroblasts derived from patients with idiopathic pulmonary fibrosis.
Journal: Toxicology and applied pharmacology
Published: December 17, 2021
Nintedanib modulates type III collagen turnover in viable precision-cut lung slices from bleomycin-treated rats and patients with pulmonary fibrosis.
Journal: Respiratory research
Published: November 26, 2021
Leveraging ageing models of pulmonary fibrosis: the efficacy of nintedanib in ageing.
Journal: The European respiratory journal
Published: March 14, 2021
The Effect of Nintedanib on T-Cell Activation, Subsets and Functions.
Journal: Drug design, development and therapy
Published: October 31, 2020
Last Updated: 09/26/2026